TF and viral infectious disease: To disrupt the capsid-vRNA interaction, we used the 9900 mutant sequence, which was engineered with silent mutations in the 6K/TF region to weaken this interaction, as previously shown by quantitative immunoprecipitation (qIP) following viral infection (Fig. 1B) (21).